Giving up on Google Drive wasn’t an easy decision. However, now that the dust has settled, my files are more organized, the ...

New products and capabilities to address four of the biggest forces shaping the future of supply chain ...

Welcome to the second installment of this comprehensive annual look at global cybersecurity industry prediction reports from ...

Rackula is a browser-based visualizer for rack layouts, designed specifically for home lab enthusiasts. It lets you design a ...

Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...

If 50/30/20 isn’t realistic for you, there are still ways to save and tackle debt. Start setting aside small quantities of ...

Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

BloodHorse has reprised its online year-end survey to ask some of the sport's leading individuals for their opinions on pertinent issues facing the sport.

CNW/ - Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) ("Eminent" or the "Company") is pleased to announce the ...

VANCOUVER, BC, Jan. 6, 2026 /CNW/ - Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) ("Eminent" or the "Company") is ...

VANCOUVER, BC, Jan. 6, 2026 /PRNewswire/ - Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) ("Eminent" or the ...